Antibodies that are a fraction of the size of a regular antibody protect against key toxins in snake venom and could potentially replace 130-year-old treatments.
Scientists and engineers teamed up to use robots to streamline cell therapy manufacturing, aiming to give more patients access to these lifesaving therapies.